Professor
NDORMS, University of Oxford, Oxford, UK, United Kingdom
Karthik Ramasamy is a Consultant Haematologist at Oxford University Hospitals NHS Trust and Associate Professor of Haematology, NDORMS, University of Oxford UK. Dr Ramasamy is the Clinical Director of the Oxford Myeloma Translational Research Centre (https://www.ndorms.ox.ac.uk/research/otmc). Karthik is an Executive member of the UK Myeloma Society and is an active member of UK Myeloma Research Alliance. Karthik serves on the Myeloma UK Board, a patient charity exclusively dealing with myeloma advocacy and research. Dr Ramasamy is a Chief Investigator of national myeloma/ MGUS studies and his translational research interests are MGUS monitoring pathways, early intervention of smouldering myeloma, high risk myeloma and myeloma drug resistance mechanisms. Dr Ramasamy completed his haematology training in London. Following this, he completed three years as a clinical research fellow working on bone marrow microenvironment in myeloma at King’s College London. Karthik has published over 150 papers and authored textbooks/ chapters on myeloma.